Gendering Drugs

This book, by bringing together critical pharmaceutical studies and feminist technoscience studies, explores the way drugs produce sexed and/or gendered identities for those who take or resist them, and how feminist technoscience studies can contribute a theoretical lens with which to observe sex and gender in the pharmaceuticalization processes. Topics explored in this diverse collection include the use of hormones to delay puberty onset for trans children; HPV vaccination against cervical cancer in Sweden, the UK, Austria and Colombia; Alzheimer's discourses; and the medication of prostate issues. Ericka Johnson has brought together an innovative and timely collection that demonstrates gender as relevant in studies of pharmaceuticals, and provides multiple examples of methodological and theoretical tools to consider gender while studying drugs.

Combines interdisciplinary feminist science studies and science and technology studies Examines how gender can be seen in critical pharmaceutical studies Argues that the pharmaceutical studies field is 'gender-blind' and provides a set of tools to change this Acts as a valuable introductory book to the growing area of gender in pharmaceutical studies

Autorentext

Ericka Johnson is Senior Lecturer and Assistant Director of Technology and Social Change at Linköping University, Sweden. Her research interests include medical bodies and subjects as refracted by medical technologies.

Inhalt

1. Introduction.- Part I. Making Scientific and Medical Truths.- 2. Alzheimer's in the Making.- 3. The Pharmaceuticalized Prostate.- 4. New Puberty; New Trans: Children, Pharmaceuticals and Politics.- Part II. Creating Subjectivities for Patients in Advertising.- 5. Prescribing Relational Subjectivities.- 6. You Will Protect Your Daughter, Right?.- Part III. Different HPV Vaccines.- 7. Evidence, Sex and State Paternalism.- 8. Young Women and the Pharmaceutical Burden of HPV Vaccinations.- 9. Two Shots for Children.- 10. Sexing Drugs, Refracting Discourses.